USF-LVHN SELECT
Residential Distance to the Cancer Center and Outcomes after Robotic-Assisted Pulmonary Lobectomy.
Publication/Presentation Date
12-1-2023
Abstract
BACKGROUND: Outcomes of lung cancer patients traveling greater distances for surgical oncology care are not well-described. We investigated the effects of increased travel burden after robotic-assisted pulmonary lobectomy (RAPL) for lung cancer.
METHODS: Clinical characteristics and surgical outcomes of 711 consecutive patients who underwent RAPL from September 2010 to March 2022 were compared, stratified by primary residential ZIP code≥160 km from the cancer center.
RESULTS: Of 711 study patients, 515 (72.4%) lived within 160 km and 196 (27.6%) lived ≥160 km away. There were no differences in Charlson Comorbidity Index scores or tumor characteristics. Those traveling ≥160 km experienced more unfavorable perioperative outcomes and postoperative complications, and had worse median survival time by 1.68 years, but this survival difference did not reach statistical significance.
CONCLUSIONS: With the growing centralization of cancer care, travel burden may emerge as a predictor of surgical oncology outcomes.
Volume
15
First Page
100210
Last Page
100210
ISSN
2666-2620
Published In/Presented At
Dumitriu Carcoana, A. O., Marek, J. C., West, W. J., 3rd, Fiedler, C. R., Doyle, W. N., Jr, Labib, K. M., Ladehoff, L. C., Malavet, J. A., Fishberger, G., Moodie, C. C., Garrett, J. R., Tew, J. R., Baldonado, J. J. A. R., Fontaine, J. P., & Toloza, E. M. (2023). Residential Distance to the Cancer Center and Outcomes after Robotic-Assisted Pulmonary Lobectomy. Surgery in practice and science, 15, 100210. https://doi.org/10.1016/j.sipas.2023.100210
Disciplines
Medical Education | Medicine and Health Sciences
PubMedID
39844799
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article